APOE and Alzheimer disease: In comparison to similar cohorts of healthy individuals, the prevalence of SVD markers in the PREVENT cohort was slightly higher,40 likely due to the oversampling of at-risk individuals, including carriers of the APOE4 allele, a well-established risk factor of SVD (particularly CAA-SVD) and AD.